Vitamin B Complex

drug
On this page

Summary

Vitamin B Complex (CHEMBL2108015) is a phase-3 clinical-stage unknown; indicated across 1 condition including hydatidiform mole.

At a glance

  • Status: Max clinical phase 3 (not approved)
  • Modality: Unknown
  • Indications: 1 condition
  • Clinical trials: 10

Identifiers

Drug identity and classification

FieldValue
ChEMBL IDCHEMBL2108015
NameVitamin B Complex
TypeUnknown
Max phase3

Also known as: Vitamin b complex, VITAMIN B COMPLEX

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

1 indication (0 at ChEMBL trial phase 4). Phase below is the highest clinical-trial phase recorded for this drug against each disease — not the molecule’s overall approval status (that is in the Summary).

IndicationTrial phaseMONDOEFO
hydatidiform mole3MONDO:0006248EFO:1000298

Clinical trials

Total trials: 10.

Phase distribution

PhaseTrials
Not specified4
PHASE43
PHASE32
PHASE21

Top trials by phase / activity

NCTPhaseStatusTitle
NCT07296354PHASE4NOT_YET_RECRUITINGEvaluation of an ATP-Containing Parenteral Vitamin B Complex in Patients With Symptomatic Diabetic Polyneuropathy
NCT07592897PHASE4NOT_YET_RECRUITINGVitamin B Complex for Inferior Alveolar Nerve Paresthesia Recovery
NCT04893733PHASE4COMPLETEDIntravenous Administration of Vitamin B Complex Improves Renal Recovery in Patients With AKI
NCT01283646PHASE3COMPLETEDEfficacy and Tolerability of Apevitin BC Comparing to Vitamin Complex in Stimulating the Appetite
NCT01984099PHASE3COMPLETEDRCT on the Efficacy of Methotrexate for the Prevention of GTD
NCT03564678PHASE2TERMINATEDLevocarnitine and Vitamin B Complex in Treating PEG-Asparaginase or Inotuzumab Ozogamicin-Induced Hyperbilirubinemia in Patients With Acute Lymphoblastic Leukemia
NCT06857734Not specifiedNOT_YET_RECRUITINGAnalgesic and Anti-inflamatory Effect of Vit. B
NCT07312123Not specifiedRECRUITINGA Study to See Whether Taking a Mix of Vitamins Can Help Adults Recover Better After Surgery for Carpal Tunnel Syndrome
NCT02537392Not specifiedCOMPLETEDMulti-micronutrient Supplementation During Peri-conception and Congenital Heart Disease
NCT07191587Not specifiedCOMPLETEDA Controlled Clinical Trial Assessing the Efficacy of Vitamin B Prophylaxis in Attenuating Paclitaxel-induced Neuropathy and the Imperative Use of Gabapentin in Diabetic Ovarian Cancer Patients and the Potential Effect on Disease Response.

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).